Vertex Pharmaceuticals Inc <VRTX.O>: Canaccord Genuity Raises Target Price to $442 From $436
VRTX•Related News
Advanced Energy to present at Citi Global TMT Conference via webcast
AEIS•
Ingredion Q2 EPS USD 1.78
INGR•
Lipocine Q2 FY26 net loss widens to $2.6 million; revenue drops to $190,099
LPCN•
Ethos Technologies Inc. <LIFE.O>: Barclays raises target price to $37 from $27
LIFE•
Trump administration drafting ban on Chinese data center devices, sources say
XLK•